Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease

被引：0
|
作者：
Jiansong Fang
Pengyue Zhang
Quan Wang
Chien-Wei Chiang
Yadi Zhou
Yuan Hou
Jielin Xu
Rui Chen
Bin Zhang
Stephen J. Lewis
James B. Leverenz
Andrew A. Pieper
Bingshan Li
Lang Li
Jeffrey Cummings
Feixiong Cheng
机构：
[1] Genomic Medicine Institute,Department of Biostatistics and Health Data Science, School of Medicine
[2] Lerner Research Institute,Department of Molecular Physiology and Biophysics
[3] Cleveland Clinic,Vanderbilt Genetics Institute
[4] Indiana University,Department of Biomedical Informatics, College of Medicine
[5] Vanderbilt University,Department of Pediatrics
[6] Vanderbilt University Medical Center,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine
[7] Ohio State University,Harrington Discovery Institute
[8] Case Western Reserve University,Department of Psychiatry
[9] Case Western Reserve University,Institute for Transformative Molecular Medicine, School of Medicine
[10] Lou Ruvo Center for Brain Health,Department of Neuroscience
[11] Neurological Institute,Chambers
[12] Cleveland Clinic,Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences
[13] University Hospitals Cleveland Medical Center,undefined
[14] Case Western Reserve University,undefined
[15] Geriatric Psychiatry,undefined
[16] GRECC,undefined
[17] Louis Stokes Cleveland VA Medical Center,undefined
[18] Case Western Reserve University,undefined
[19] Case Western Reserve University,undefined
[20] School of Medicine,undefined
[21] University of Nevada Las Vegas,undefined
[22] Case Comprehensive Cancer Center,undefined
来源：
Alzheimer's Research & Therapy | / 14卷
关键词：
Alzheimer’s disease; Drug repurposing; Genome-wide association studies (GWAS); Multi-omics; Network medicine; Pioglitazone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Current drug targets for Alzheimer's disease treatment
    Lahiri, DK
    Farlow, MR
    Greig, NH
    Sambamurti, K
    DRUG DEVELOPMENT RESEARCH, 2002, 56 (03) : 267 - 281
  • [42] Secretases as targets for drug design in Alzheimer's disease
    Hendriksen, JVRB
    Nottet, HSLM
    Smits, HA
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (01) : 60 - 68
  • [43] Molecular drug targets and therapies for Alzheimer's disease
    Singh, Dev Bukhsh
    Gupta, Manish Kumar
    Kesharwani, Rajesh Kumar
    Sagar, Mamta
    Dwivedi, Seema
    Misra, Krishna
    TRANSLATIONAL NEUROSCIENCE, 2014, 5 (03) : 203 - 217
  • [44] Artificial intelligence-based computational framework for drug-target prioritization and inference of novel repositionable drugs for Alzheimer’s disease
    Shingo Tsuji
    Takeshi Hase
    Ayako Yachie-Kinoshita
    Taiko Nishino
    Samik Ghosh
    Masataka Kikuchi
    Kazuro Shimokawa
    Hiroyuki Aburatani
    Hiroaki Kitano
    Hiroshi Tanaka
    Alzheimer's Research & Therapy, 13
  • [45] Artificial intelligence-based computational framework for drug-target prioritization and inference of novel repositionable drugs for Alzheimer's disease
    Tsuji, Shingo
    Hase, Takeshi
    Yachie-Kinoshita, Ayako
    Nishino, Taiko
    Ghosh, Samik
    Kikuchi, Masataka
    Shimokawa, Kazuro
    Aburatani, Hiroyuki
    Kitano, Hiroaki
    Tanaka, Hiroshi
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [46] Genome-Wide Mendelian Randomization Identifies Ferroptosis-Related Drug Targets for Alzheimer's Disease
    Wang, Ying
    Song, Xinhua
    Wang, Rui
    Xu, Xinzi
    Du, Yaming
    Chen, Guohua
    Mei, Junhua
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2024, 8 (01) : 1185 - 1197
  • [47] Repurposing of Tibolone in Alzheimer's Disease
    Barreto, George E.
    BIOMOLECULES, 2023, 13 (07)
  • [48] Editorial: Artificial Intelligence in Bioinformatics and Drug Repurposing: Methods and Applications
    Zheng, Pan
    Wang, Shudong
    Wang, Xun
    Zeng, Xiangxiang
    FRONTIERS IN GENETICS, 2022, 13
  • [49] New drug candidate discovered for the treatment of Alzheimer's disease
    不详
    FUTURE NEUROLOGY, 2008, 3 (04) : 373 - 373
  • [50] Application of Artificial Intelligence in COVID-19 drug repurposing
    Mohanty, Sweta
    Rashid, Md Harun A., I
    Mridul, Mayank
    Mohanty, Chandana
    Swayamsiddha, Swati
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (05) : 1027 - 1031
12345